Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
Professor Raoult of IHU Méditerannée in Marseille, France received today a mark of support from world-class scientists and doctors in a letter initiated by non-profit organization BonSens.org. This was sparkled by an article published in Le Monde by a group of french doctors in opposition to the recent publication of Professor Raoult and his team regarding the positive effect of early treatment with hydroxychloroquine on 30 423 patients.
First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg, France60 patients across France and Belgium to take part in a trial which aims to assess the toxicity and efficacy of the.
EverImmune appoints scientific advisory board of four international experts in cancer immunotherapy and oncobiotics (the study of interactions between the microbiome and cancer cells)As specialists in oncology, microbiology and immunology, they will support the company in developing its product portfolioVillejuif-Gr.